Exploration of Immunogenic Cell Death-Associated Genes for Predicting Prognosis and Immunological Characteristics in Cervical Squamous Cell Carcinoma

Figure 5

Validation of an ICDGs-based risk score. ROC curves demonstrated the predictive efficiency of the risk score, TCGA cohort (a) and GSE44001 (b). Kaplan–Meier survival analysis for CSCC patients with distinct risk groups, TCGA cohort (c), GSE44001 (d). (e) Construction of a nomogram combining FIGO_stage and risk score. (f–g) Calibration plot showing that the nomogram-predicted survival probabilities corresponded closely to the observed proportions.

(a)

(b)

(c)

(d)

(e)

(f)

(g)